Skip to main content

AddLife Value Stock - Dividend - Research Selection

AddLife AB

ISIN: SE0014401378, WKN: A2P4TH

Market price date: 17.09.2021
Market price: 390,00 SEK


AddLife AB Fundamental data and company key figures of the share

Annual reports in SEK
Key figures 07-09-2021
Cash flow
Net operating cash flow 950.100.000
Capital Expenditures -62.700.000
Free cash flow 887.400.000
Balance sheet
Total Equity 1.890.000.000
Liabilities & Shareholders equity 4.150.000.000
Income statement
Net income 518.000.000
Eps (diluted) 4,640
Diluted shares outstanding 111.637.000
Net sales/revenue 5.273.000.000

Fundamental ratios calculated on: 17-09-2021

Ratios
Key figures 17-09-2021
Cash flow
P/C 42,18
   
P/FC 49,06
Balance sheet
ROI12,48
ROE45,54
Income statement
P/E84,05
Div. Yield0,42%
P/B21,21
P/S8,26


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolALIF-B.ST
Market Capitalization4.519.512.576,00 USD
Country
Indices
SectorsHealth Care Services
Raw Data SourceIFRS in Millionen SEK
Stock Split2020-05-27,4.000000/1.000000
Internetwww.add.life


Description of the company

AddLife AB (publ), together with its subsidiaries, supplies equipment, instruments, and reagents to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries in Sweden, Finland, Denmark, Norway, and internationally. The company operates through two segments, Labtech and Medtech. The Labtech segment provides analysis instruments, equipment, microscopes, consumables and reagents, as well as software support and technical services primarily to laboratories in medicine, research, academia, food, pharmaceutical, microbiology, clinical chemistry, coagulation, molecular biology, immunology, point-of-care testing, and veterinary diagnostics industries. This segment also offers training programs, seminars, and advisory services. The Medtech segment provides medical device products to surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare markets. AddLife AB (publ) was founded in 1906 and is headquartered in Stockholm, Sweden.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.add.life


NEWS